Literature DB >> 16681673

Subungual metastasis from a rectal primary: case report and review of the literature.

Barry Gallagher1, George Yousef, Leigh Bishop.   

Abstract

BACKGROUND: Subungual metastases from colorectal cancer are unusual and have mainly been reported in patients with lung, genitourinary, and breast cancer.
OBJECTIVE: We present the case of a 72-year-old man with rectal adenocarcinoma and a subungual metastasis to the left thumb 5 years later.
METHODS: A case report and a brief review of the literature of subungual metastases are given.
RESULTS: The thumb was amputated and the patient died 6 months later with extensive metastatic disease.
CONCLUSION: Metastatic carcinoma should be considered in the differential diagnosis of persistent subungual masses, particularly in patients with a history of cancer. The prognosis with such lesions is generally poor.

Entities:  

Mesh:

Year:  2006        PMID: 16681673     DOI: 10.1111/j.1524-4725.2006.32111.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  4 in total

1.  Ileocecal adenocarcinoma with overexpression of P53 protein metastasized to the thenar muscle: report of a rare case and review of literature.

Authors:  Cuihua Yi; Zhiyan Liu; Yunxia Chu; Shuguang Li; Lian Liu; Jisheng Li; Xuejun Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Cutaneous metastases secondary to colorectal carcinoma may not be as ominous as previously thought: a case report and review of the literature.

Authors:  Biju Aravind; Rohan Kumar; Pradeep Basnyat
Journal:  BMJ Case Rep       Date:  2013-07-02

Review 3.  Metastases to the nail unit and distal phalanx: a systematic review.

Authors:  Kaya L Curtis; Shari R Lipner
Journal:  Arch Dermatol Res       Date:  2022-10-19       Impact factor: 3.033

4.  Two cases of acrometastasis to the hands and review of the literature.

Authors:  C J Flynn; C Danjoux; J Wong; M Christakis; J Rubenstein; A Yee; D Yip; E Chow
Journal:  Curr Oncol       Date:  2008-10       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.